(EMAILWIRE.COM, September 08, 2018 ) The global empty capsules market is highly consolidated. The market is dominated by Capsugel (U.S.), ACG Worldwide (India), and Qualicaps, Inc. (U.S.), which together accounted for around three-fourths of the global market in 2015. The dominance of the above companies can be attributed to their wide geographic footprints, strong product portfolios, and large established client bases.
Capsugel (U.S.) was the leading market player in the empty capsules market in 2015, owing to its strong product portfolio, consisting of empty and two-piece hard capsules in the form of hard gelatin, vegetarian, and liquid-filled capsules. The company has a strong presence in more than 100 countries across Asia-Pacific, Europe, North America, Central America, and Latin America. ACG Worldwide was the second-largest player in the empty capsules market in 2015. It is one of the largest global manufacturers of pharmaceutical empty hard gelatin capsules. ACG ACPL, a subsidiary of ACG Worldwide, mainly serves the global dietary supplement and pharmaceutical industry, serving more than 80% of Asias pharmaceutical prescription market. Qualicaps, Inc. (U.S.) held the third-largest share of the empty capsules market in 2015.

PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=218018190

Industry players adopted various strategies to achieve growth in the empty capsules market; however, the major strategy used between 2013 and 2016 to achieve growth globally was expansions. In July 2015, Capsugel expanded its facility in Edinburgh, Scotland to meet the rising customer demand for its specialized products. Acquisitions and new product launches were the other strategies adopted by the top players in the empty capsules market. In March 2013, Medi-Caps Ltd. (India) acquired Medgel Pvt. Ltd. (India) to enhance its product portfolio and market share in the empty capsules market. Product differentiation is another key strategy that companies are focusing on to meet the increasing demand for innovative products and technologies. In October 2015, Capsugel launched a new technology which makes vegetarian, acid-resistant DRcaps hard capsules suitable for liquid-fill applications.

Growing consumer preference towards capsule-based formulations is another major factor driving the demand for empty capsules in the pharmaceutical and nutraceutical industry. Research studies indicate that a drug which is consumed by patients in the capsule form is more regularly and consistently consumed. Moreover, capsules are highly preferred over tablets among consumers of herbal products as they are easy to swallow. Similar trends are also observed in the pharmaceutical industry as well, where nearly two-thirds of patients prefer capsule-based formulations over tablets and other dosage forms.

Technological developments have given rise to a wide range of alternate options for capsules with similar functionalities. Technological advancements have also resulted in the integration of various formulations for both pharmaceutical as well as nutraceutical products. A wide range of benefits are associated with this innovative technology, including minimal excipients required for formulations, improvements in upper gastrointestinal safety, differentiated pharmacokinetic performance, and accelerated product development. Thus, in a competitive environment, factors such as technological innovations in terms of development of gastro-resistant capsules and modified-release capsules are expected to increase the demand for empty capsules in the pharmaceutical and nutraceutical industries.

Know More: https://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.